These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7941971)

  • 21. Prolonged alcohol intake leads to reversible depression of corticotropin-releasing hormone and vasopressin immunoreactivity and mRNA levels in the parvocellular neurons of the paraventricular nucleus.
    Silva SM; Paula-Barbosa MM; Madeira MD
    Brain Res; 2002 Nov; 954(1):82-93. PubMed ID: 12393236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distribution of MT1 melatonin receptor immunoreactivity in the human hypothalamus and pituitary gland: colocalization of MT1 with vasopressin, oxytocin, and corticotropin-releasing hormone.
    Wu YH; Zhou JN; Balesar R; Unmehopa U; Bao A; Jockers R; Van Heerikhuize J; Swaab DF
    J Comp Neurol; 2006 Dec; 499(6):897-910. PubMed ID: 17072839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for a functional and anatomical relationship between the lateral septum and the hypothalamus in the control of flank marking behavior in Golden hamsters.
    Ferris CF; Gold L; De Vries GJ; Potegal M
    J Comp Neurol; 1990 Mar; 293(3):476-85. PubMed ID: 2324325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systemic endotoxin increases steady-state gene expression of hypothalamic nitric oxide synthase: comparison with corticotropin-releasing factor and vasopressin gene transcripts.
    Lee S; Barbanel G; Rivier C
    Brain Res; 1995 Dec; 705(1-2):136-48. PubMed ID: 8821744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical localization of corticotropin-releasing factor, [arginine8]-vasopressin and oxytocin neurons in the goat hypothalamus.
    Kikusui T; Takeuchi Y; Mori Y
    J Vet Med Sci; 1997 Aug; 59(8):621-8. PubMed ID: 9300356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Demonstration of glucocorticoid receptor-like immunoreactivity in glucocorticoid-sensitive vasopressin and corticotropin-releasing factor neurons in the hypothalamic paraventricular nucleus.
    Uht RM; McKelvy JF; Harrison RW; Bohn MC
    J Neurosci Res; 1988 Apr; 19(4):405-11, 468-9. PubMed ID: 3260289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Downregulation of corticotropin-releasing factor mRNA, but not vasopressin mRNA, in the paraventricular hypothalamic nucleus of rats following nutritional stress.
    Hwang BH; Guntz JM
    Brain Res Bull; 1997; 43(5):509-14. PubMed ID: 9250625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impaired hypothalamus-pituitary-adrenal axis activity and more severe multiple sclerosis with hypothalamic lesions.
    Huitinga I; Erkut ZA; van Beurden D; Swaab DF
    Ann Neurol; 2004 Jan; 55(1):37-45. PubMed ID: 14705110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stress-induced increase in vasopressin and corticotropin-releasing factor expression in hypophysiotrophic paraventricular neurons.
    Bartanusz V; Jezova D; Bertini LT; Tilders FJ; Aubry JM; Kiss JZ
    Endocrinology; 1993 Feb; 132(2):895-902. PubMed ID: 8425502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pathological changes in peripheral organs of scrapie-infected animals.
    Ye X; Carp RI
    Histol Histopathol; 1995 Oct; 10(4):995-1021. PubMed ID: 8574018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Margination and diapedesis of inflammatory cells in the islets of Langerhans in hamsters infected with the 139H strain of scrapie.
    Ye X; Carp RI
    J Comp Pathol; 1996 Feb; 114(2):149-63. PubMed ID: 8920215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of chronic alcoholic disease on magnocellular and parvocellular hypothalamic neurons in men.
    Sivukhina EV; Dolzhikov AA; Morozov IuE; Jirikowski GF; Grinevich V
    Horm Metab Res; 2006 Jun; 38(6):382-90. PubMed ID: 16823720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistent elevation of corticotrophin releasing factor and vasopressin but not oxytocin mRNA in the rat after kindled seizures.
    Greenwood RS; Fan Z; Meeker R
    Neurosci Lett; 1997 Mar; 224(1):66-70. PubMed ID: 9132693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunocytochemical identification of vasopressinergic and oxytocinergic neurons in the hypothalamus of the cat.
    Reaves TA; Hayward JN
    Cell Tissue Res; 1979 Jan; 196(1):117-22. PubMed ID: 421243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Local Corticotropin-Releasing Factor Signaling in the Hypothalamic Paraventricular Nucleus.
    Jiang Z; Rajamanickam S; Justice NJ
    J Neurosci; 2018 Feb; 38(8):1874-1890. PubMed ID: 29352046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of hypophysectomy on the hypothalamic corticotropin-releasing factor (CRF) neuronal system in the eel: immunocytochemical study.
    Olivereau M; Olivereau J
    Neurosci Lett; 1988 Sep; 91(3):271-5. PubMed ID: 3263590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interactions between vasopressin- and gonadotropin-releasing-hormone-containing neuroendocrine neurons in the monkey supraoptic nucleus.
    Thind KK; Boggan JE; Goldsmith PC
    Neuroendocrinology; 1991 Mar; 53(3):287-97. PubMed ID: 1710332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Astrocytosis and proliferating cell nuclear antigen expression in brains of scrapie-infected hamsters.
    Ye X; Scallet AC; Kascsak RJ; Carp RI
    J Mol Neurosci; 1998 Dec; 11(3):253-63. PubMed ID: 10344795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential regulation of corticotropin-releasing factor and vasopressin in discrete brain regions after morphine administration: correlations with hypothalamic noradrenergic activity and pituitary-adrenal response.
    Milanés MV; Laorden ML; Chapleur-Château M; Burlet A
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Nov; 356(5):603-10. PubMed ID: 9402040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fos induction in selective hypothalamic neuroendocrine and medullary nuclei by intravenous injection of urocortin and corticotropin-releasing factor in rats.
    Wang L; Martínez V; Vale W; Taché Y
    Brain Res; 2000 Feb; 855(1):47-57. PubMed ID: 10650129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.